Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Neurologists create a font of human nerve cells

16.02.2004


Scientists have created an unlimited supply of a type of nerve cell found in the spinal cord – a self-renewing cell line that offers a limitless supply of human nerve cells in the laboratory. Such a supply has long been one goal of neurologists anxious to replace dead or dying cells with healthy ones in a host of neurological diseases.



In this study, appearing in the March issue of Nature Biotechnology, the scientists then used the cells to partially repair damaged spinal cords in laboratory animals, re-growing small sections of the spinal cord that had been damaged. Doctors emphasize that tests in people with damaged spinal cords or other neurological conditions are a long ways off.

The researchers, led by neurologist Steven Goldman, M.D., Ph.D., of the University of Rochester Medical Center, created the unique cells by introducing a gene called telomerase, which is responsible for the ability of stem cells to live indefinitely, into more specialized "progenitor" cells. In normal development, these progenitor cells give rise to very specific types of spinal neurons, but they do so for only short periods of time, because they lack the ability to continuously divide. With the newly added telomerase gene, the spinal progenitor cells were able to continuously divide while still producing only specific types of neurons. The outcome was a line of immortal progenitor cells, capable of churning out human spinal neurons indefinitely.


While stem cells receive a great deal of attention as a possible source of life-saving treatments, progenitor cells offer great potential, Goldman says. To be sure, progenitor cells lack a key feature of stem cells: Their potential to become nearly any type of cell. But what progenitor cells lack in potential, they make up for with commitment: They have already "decided" exactly what type of cell to become in the body, an advantage when treating a disease where one specific cell type is at risk. A patient with Parkinson’s disease, for example, may only needs to replace dopamine-producing neurons, while in patients with multiple sclerosis, only cells that produce myelin need be restored.

Since committed progenitor cell normally can divide for only a limited number of times, until now scientists have been unable to produce enough to make a difference clinically. Goldman’s team solved the problem by introducing the gene for telomerase at just the right moment in the cell’s lifetime, when it has committed to a particular spinal cell type, thus immortalizing the cells at this key juncture. The result was a line of immortal progenitor cells giving rise only to human spinal neurons, including both motor neurons and interneurons, two of the most clinically important cell types of the spinal cord.

"The progenitor cells are immortalized at a stage when they only give rise to the type of neuron we want, thus becoming an ongoing source of these neurons," says Goldman, who is professor of Neurology and chief of the department’s Division of Cell and Gene Therapy.

Goldman’s team propagated these cells for over two years, the longest anyone has ever maintained such a line of neuronal progenitor cells. With these select neurons in hand, Goldman’s colleagues, led by Maiken Nedergaard, M.D., Ph.D., professor of Neurosurgery, then injected the modified progenitors into rats and found that the cells replaced damaged parts of the spinal cord with new nerve cells.

A key finding was the lack of tumors, or any tendency toward tumor growth, says Goldman. Telomerase is one of the ingredients that cancer cells needs to survive, and previous work had indicated that turning the gene for telomerase on could heighten the risk of tumors. But the group followed the rats closely for six months, and the cells in the laboratory for two years, and found no increase in tumors or a tendency to develop into tumors. After about a month, the cells in the animals stopped proliferating, as neurons in the spinal cord normally do.

Since the spinal cord is made up of several types of neurons, the group now is creating and working with other cells that would create other types of neurons necessary to repair spinal cord tissue.

"This work is the culmination of six years of work, and it will be many more years before an approach like this can be tried in human patients. But the promise is extraordinary," says Goldman, whose project was funded by Project ALS and the Christopher Reeve Paralysis Foundation.


From Rochester, other authors include Martha Windrem, Ph.D. Other authors include Neeta Roy, Takahiro Nakano, H. Michael Keyoung, William Rashbaum, M. Lita Alonso, Jian Kang, Weiguo Peng, and Jane Lin of Cornell, and Melissa Carpenter of Geron Corp., who is now at the Robarts Research Institute in Canada.

Tom Rickey | EurekAlert!
Further information:
http://www.urmc.rochester.edu/

More articles from Life Sciences:

nachricht Researchers identify potentially druggable mutant p53 proteins that promote cancer growth
09.12.2016 | Cold Spring Harbor Laboratory

nachricht Plant-based substance boosts eyelash growth
09.12.2016 | Fraunhofer-Institut für Angewandte Polymerforschung IAP

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>